ZA200005510B - Pharmaceutical composition. - Google Patents

Pharmaceutical composition.

Info

Publication number: ZA200005510B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 1998-04-14

Application number

ZA200005510A

Other languages

English (en)

Inventor

Raimund Margreiter

Gunther Konwalinka

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-14

Filing date

2000-10-09

Publication date

2001-05-08

2000-10-09 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2001-05-08 Publication of ZA200005510B publication Critical patent/ZA200005510B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Diabetes (AREA)
Hematology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Virology (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Obesity (AREA)
Tropical Medicine & Parasitology (AREA)
Endocrinology (AREA)
AIDS & HIV (AREA)
Gastroenterology & Hepatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)

ZA200005510A 1998-04-14 2000-10-09 Pharmaceutical composition. ZA200005510B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AT63698		1998-04-14

Publications (1)

Publication Number	Publication Date
ZA200005510B true ZA200005510B (en)	2001-05-08

Family

ID=3495843

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200005510A ZA200005510B (en)	1998-04-14	2000-10-09	Pharmaceutical composition.

Country Status (27)

Country	Link
US (1)	US6555518B1 (xx)
EP (1)	EP1071433B1 (xx)
JP (1)	JP2002511405A (xx)
KR (1)	KR100450248B1 (xx)
CN (1)	CN1312719A (xx)
AR (1)	AR019053A1 (xx)
AT (1)	ATE229338T1 (xx)
AU (1)	AU3126799A (xx)
BR (1)	BR9909617A (xx)
CA (1)	CA2327431A1 (xx)
CO (1)	CO5011041A1 (xx)
DE (1)	DE59903751D1 (xx)
DK (1)	DK1071433T3 (xx)
EA (1)	EA200001061A1 (xx)
ES (1)	ES2190647T3 (xx)
HU (1)	HUP0102671A3 (xx)
ID (1)	ID27201A (xx)
IL (2)	IL138888A0 (xx)
NO (1)	NO20005179D0 (xx)
PE (1)	PE20000424A1 (xx)
PL (1)	PL343769A1 (xx)
PT (1)	PT1071433E (xx)
SV (1)	SV1999000039A (xx)
TR (2)	TR200002969T2 (xx)
TW (1)	TW466112B (xx)
WO (1)	WO1999052514A2 (xx)
ZA (1)	ZA200005510B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATA173599A (de) *	1999-10-14	2001-04-15	Lilly Co Eli	Pharmazeutisches produkt
MY164523A (en) *	2000-05-23	2017-12-29	Univ Degli Studi Cagliari	Methods and compositions for treating hepatitis c virus
CA2410579C (en)	2000-05-26	2010-04-20	Jean-Pierre Sommadossi	Methods and compositions for treating flaviviruses and pestiviruses
TWI233359B (en) *	2001-04-06	2005-06-01	Wyeth Corp	Pharmaceutical composition for treating neoplasm
CN1309421C (zh) *	2001-04-06	2007-04-11	惠氏公司	诸如雷帕霉素和吉西他滨或氟尿嘧啶的抗肿瘤联合
TWI296196B (en) *	2001-04-06	2008-05-01	Wyeth Corp	Antineoplastic combinations
ZA200603888B (en) *	2001-06-01	2007-05-30	Wyeth Corp	Antineoplastic combinations
BR0307712A (pt) *	2002-02-14	2005-05-24	Pharmasset Ltd	Composto, composição e uso dos mesmos no tratamento de infecções por flaviviridae e proliferação celular anormal
CN101172993A (zh)	2002-06-28	2008-05-07	埃迪尼克斯(开曼)有限公司	用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
JP2006519753A (ja)	2002-11-15	2006-08-31	イデニクス（ケイマン）リミテツド	２’−分枝ヌクレオシドおよびフラビウイルス科ウイルス突然変異
MXPA05006230A (es)	2002-12-12	2005-09-20	Idenix Cayman Ltd	Proceso para la produccion de nucleosidos ramificados-2'.
DE10323279A1 (de) *	2003-05-21	2004-12-16	Stada Arzneimittel Ag	Gebrauchsfertige Gemcitabin-Lösungen
DE10323278A1 (de) *	2003-05-21	2004-12-16	Stada Arzneimittel Ag	Gebrauchsfertige Gemcitabin-Lösungskonzentrate
ES2259552B1 (es) *	2005-03-17	2007-06-16	Proyecto De Biomedicina Cima, S.L.	Empleo de 5'-metiltioadenosina (mta) en la prevencion y/o tratamiento de enfermedades autoinmunes y/o rechazo de transplantes.
CA2601557A1 (en) *	2005-03-17	2006-09-21	Proyteco De Biomedicina Cima, S.L.	Use of 5'-methylthioadenosine (mta) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection
AT502221A1 (de) *	2005-07-20	2007-02-15	Pharmacon Forschung & Beratung Gmbh	Homogemcitabine, verfahren zu ihrer herstellung sowie deren verwendung
CA2757743C (en)	2009-04-06	2017-10-10	Eisai Inc.	(2'-deoxy-ribofuranosyl)-1,3,4,7-tetrahydro-(1,3) diazepin-2-0ne derivatives for treating cancer
SMT201800366T1 (it)	2012-04-04	2018-09-13	Halozyme Inc	Combinazione terapia con ialuronidasi e taxano mirato al tumore
CN107184592A (zh) *	2017-05-17	2017-09-22	广东艾时代生物科技有限责任公司	吉西他滨在制备治疗类风湿性关节炎药物中的应用
WO2019222435A1 (en)	2018-05-16	2019-11-21	Halozyme, Inc.	Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
CN111655710B (zh)	2018-06-29	2021-12-21	上海长乘医药科技有限公司	吉西他滨含磷前药
RU2764742C1 (ru) *	2021-04-09	2022-01-20	Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ТИО им. академика В.И. Шумакова" Минздрава России)	Способ подбора режима иммуносупрессии детям раннего возраста в отдаленном периоде после трансплантации печени

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4526988A (en) *	1983-03-10	1985-07-02	Eli Lilly And Company	Difluoro antivirals and intermediate therefor
EP0184365B1 (en) *	1984-12-04	1993-08-04	Eli Lilly And Company	Improvements in the treatment of tumors in mammals
US4914028A (en) *	1988-02-10	1990-04-03	Eli Lilly And Company	Method of preparing beta-2',2'-difluoronucleosides
JPH0232093A (ja) *	1988-06-08	1990-02-01	Merrell Dow Pharmaceut Inc	抗レトロウィルスジフルオロ化ヌクレオシド類
AU4134793A (en) *	1992-06-22	1993-12-23	Eli Lilly And Company	2'-deoxy-2',2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates
US6291504B1 (en) *	1999-10-20	2001-09-18	Dupont Pharmaceuticals Company	Acylsemicarbazides and their uses

1999
- 1999-04-09 TW TW088105804A patent/TW466112B/zh active
- 1999-04-12 PE PE1999000297A patent/PE20000424A1/es not_active Application Discontinuation
- 1999-04-13 CO CO99021850A patent/CO5011041A1/es unknown
- 1999-04-13 SV SV1999000039A patent/SV1999000039A/es unknown
- 1999-04-13 AR ARP990101686A patent/AR019053A1/es unknown
- 1999-04-14 AT AT99912962T patent/ATE229338T1/de not_active IP Right Cessation
- 1999-04-14 HU HU0102671A patent/HUP0102671A3/hu unknown
- 1999-04-14 TR TR2000/02969T patent/TR200002969T2/xx unknown
- 1999-04-14 CA CA002327431A patent/CA2327431A1/en not_active Abandoned
- 1999-04-14 PT PT99912962T patent/PT1071433E/pt unknown
- 1999-04-14 AU AU31267/99A patent/AU3126799A/en not_active Abandoned
- 1999-04-14 CN CN99807371A patent/CN1312719A/zh active Pending
- 1999-04-14 WO PCT/AT1999/000093 patent/WO1999052514A2/de not_active Ceased
- 1999-04-14 JP JP2000543124A patent/JP2002511405A/ja active Pending
- 1999-04-14 KR KR10-2000-7011402A patent/KR100450248B1/ko not_active Expired - Fee Related
- 1999-04-14 TR TR2001/01633T patent/TR200101633T2/xx unknown
- 1999-04-14 ID IDW20002331A patent/ID27201A/id unknown
- 1999-04-14 ES ES99912962T patent/ES2190647T3/es not_active Expired - Lifetime
- 1999-04-14 EP EP99912962A patent/EP1071433B1/de not_active Expired - Lifetime
- 1999-04-14 DE DE59903751T patent/DE59903751D1/de not_active Expired - Fee Related
- 1999-04-14 PL PL99343769A patent/PL343769A1/xx unknown
- 1999-04-14 DK DK99912962T patent/DK1071433T3/da active
- 1999-04-14 IL IL13888899A patent/IL138888A0/xx unknown
- 1999-04-14 EA EA200001061A patent/EA200001061A1/ru unknown
- 1999-04-14 BR BR9909617-0A patent/BR9909617A/pt not_active Application Discontinuation
2000
- 2000-10-05 IL IL138888A patent/IL138888A/en not_active IP Right Cessation
- 2000-10-09 ZA ZA200005510A patent/ZA200005510B/xx unknown
- 2000-10-13 US US09/687,565 patent/US6555518B1/en not_active Expired - Fee Related
- 2000-10-13 NO NO20005179A patent/NO20005179D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TW466112B (en)	2001-12-01
KR100450248B1 (ko)	2004-09-24
WO1999052514A3 (de)	2000-07-06
AU3126799A (en)	1999-11-01
KR20010034779A (ko)	2001-04-25
PL343769A1 (en)	2001-09-10
ATE229338T1 (de)	2002-12-15
BR9909617A (pt)	2000-12-12
DE59903751D1 (de)	2003-01-23
NO20005179L (no)	2000-10-13
EP1071433A2 (de)	2001-01-31
EP1071433B1 (de)	2002-12-11
IL138888A0 (en)	2001-11-25
HUP0102671A2 (hu)	2001-12-28
CA2327431A1 (en)	1999-10-21
JP2002511405A (ja)	2002-04-16
DK1071433T3 (da)	2003-04-07
NO20005179D0 (no)	2000-10-13
IL138888A (en)	2009-05-04
PE20000424A1 (es)	2000-05-19
ID27201A (id)	2001-03-08
CO5011041A1 (es)	2001-02-28
HUP0102671A3 (en)	2002-04-29
AR019053A1 (es)	2001-12-26
WO1999052514A2 (de)	1999-10-21
ES2190647T3 (es)	2003-08-01
TR200101633T2 (tr)	2002-06-21
EA200001061A1 (ru)	2001-04-23
TR200002969T2 (tr)	2001-01-22
SV1999000039A (es)	1999-11-25
US6555518B1 (en)	2003-04-29
PT1071433E (pt)	2003-04-30
CN1312719A (zh)	2001-09-12

Publication	Publication Date	Title
MXPA01010676A (es)	2003-08-20	Composicion farmaceutica de vitamina d o un analogo de vitamina d y al menos un corticoesteroide.
ZA993338B (en)	2000-11-14	Pharmaceutical formulations.
ZA99454B (en)	2000-10-23	Novel dosage form.
ZA9710927B (en)	1998-06-15	Pharmaceutical composition.
ZA9710071B (en)	1998-05-25	Pharmaceutical composition.
HUP0102483A3 (en)	2002-11-28	Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol
ZA974735B (en)	1997-12-01	Pharmaceutical compositions.
GB9827996D0 (en)	1999-02-10	Pharmaceutical Compositions
ZA200005510B (en)	2001-05-08	Pharmaceutical composition.
PT1466615E (pt)	2009-09-07	Composição farmacêutica
ZA200000857B (en)	2001-05-31	Pharmaceutical composition.
ZA977104B (en)	1998-02-18	Pharmaceutical compositions.
ZA9710272B (en)	1998-06-10	Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds.
GB9818591D0 (en)	1998-10-21	Pharmaceutical composition
ZA989680B (en)	1999-07-23	Pharmaceutical composition.
GB9809213D0 (en)	1998-07-01	Pharmaceutical compositions
ZA987392B (en)	2000-02-17	Pharmaceutical composition.
ZA991232B (en)	1999-09-17	New compound and pharmaceutical compositions thereof.
ZA972602B (en)	1997-09-29	Pharmaceutical compositions.
ZA200006118B (en)	2002-01-30	Novel composition.
ZA99890B (en)	2000-08-04	Pharmaceutical compositions.
ZA200000192B (en)	2000-08-07	Novel composition.
GB9806487D0 (en)	1998-05-27	Pharmaceutical compositions
ZA994697B (en)	2000-01-31	Pharmaceutical formulation.
ZA981739B (en)	1999-09-02	Composition.